Which ETFs own GRFS?
Grifols, S.A. · Healthcare · Drug Manufacturers - General · ES — 13 ETFs hold it, worth $29.1M across 3.91M shares.
Holdings as of Oct 10, 2026 · portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | BSMC Brandes U.S. Small-Mid Cap Value ETF | 1.57% | 344.05K | $2.6M | $167.5M | Us Mid Cap | -0.32% | |
| 2 | BINV Brandes International ETF | 1.32% | 921.14K | $6.9M | $524.9M | Developed Markets | +0.60% | |
| 3 | AIIQ AI Powered International Equity ETF | 1.24% | 1.98K | $25.6K | $4.9M | Artificial Intelligence | -0.02% | |
| 4 | QQQS Invesco NASDAQ Future Gen 200 ETF | 0.51% | 15.54K | $115.9K | $22.4M | Developed Markets | +1.39% | |
| 5 | IBB iShares Biotechnology ETF | 0.13% | 1.80M | $13.3M | $10.28B | Biotech | +3.00% | |
| 6 | KOMP State Street SPDR S&P Kensho New… | 0.10% | 348.00K | $2.6M | $2.61B | Artificial Intelligence | +1.13% | |
| 7 | IBBQ Invesco Nasdaq Biotechnology ETF | 0.06% | 9.04K | $67.4K | $108.3M | Biotech | +2.96% | |
| 8 | AVNC Avantis All International Core Equity… | 0.04% | 5.79K | $42.9K | $97.2M | Developed Markets | 0.00% | |
| 9 | BIB ProShares Ultra Nasdaq Biotechnology | 0.04% | 4.69K | $35.0K | $93.2M | Biotech | +5.68% | |
| 10 | CGIC Capital Group International Core Equity… | 0.04% | 120.71K | $894.5K | $2.59B | Preferred Stocks | +0.62% | |
| 11 | DMRI DeltaShares S&P International Managed… | 0.03% | 2.72K | $94.6K | $9.5M | Treasury Bonds | -0.98% | |
| 12 | APIE ActivePassive International Equity ETF | 0.02% | 28.27K | $210.9K | $1.13B | Developed Markets | +0.65% | |
| 13 | SPDW State Street SPDR Portfolio Developed… | 0.01% | 308.77K | $2.3M | $40.46B | Developed Markets | +0.64% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.